Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat

Anesthesiology

Volumn 114, Issue 2, 2011, Pages 340-354

  Yuan, Li Bang ^a   Dong, Hai Long ^a   Zhang, Hao Peng ^a   Zhao, Rui Ni ^b   Gong, Gu ^c   Chen, Xiao Mei ^a   Zhang, Li Na ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(3(50 HYDROXYMETHYL 20-FURYL) 1 BENZYLINDAZOLE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEUROPROTECTIVE AGENT; OREXIN A; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STROKE; TRANSIENT ISCHEMIC ATTACK; WESTERN BLOTTING;

EID: 79251630525     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318206ff6f     Document Type: Article

References (49)

1. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-85
2. Nishino S: The hypocretin/orexin system in health and disease. Biol Psychiatry 2003; 54:87-95
3. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M: To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001; 24:429-58
4. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-7
5. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M: Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999; 98:437-51
6. Dong HL, Fukuda S, Murata E, Zhu Z, Higuchi T: Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia. ANESTHESIOLOGY 2006; 104:1023-32
7. Dong H, Niu J, Su B, Zhu Z, Lv Y, Li Y, Xiong L: Activation of orexin signal in basal forebrain facilitates the emergence from sevoflurane anesthesia in rat. Neuropeptides 2009; 43: 179-85
8. Nishino S, Kanbayashi T: Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005; 9:269-310
9. Culebras A: Cerebrovascular disease and sleep. Curr Neurol Neurosci Rep 2004; 4:164-9
10. Rousseaux M, Muller P, Gahide I, Mottin Y, Romon M: Disorders of smell, taste, and food intake in a patient with a dorsomedial thalamic infarct. Stroke 1996; 27:2328-30
11. Espiner EA, Leikis R, Ferch RD, MacFarlane MR, Bonkowski JA, Frampton CM, Richards AM: The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 2002; 56:629-35
12. Payne RS, Tseng MT, Schurr A: The glucose paradox of cerebral ischemia: Evidence for corticosterone involvement. Brain Res 2003; 971:9-17
13. Dohi K, Ripley B, Fujiki N, Ohtaki H, Shioda S, Aruga T, Nishino S: CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides 2005; 26:2339-43
14. Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, Upton N, Parsons AA: Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett 2002; 324:53-6
15. Dohi K, Nishino S, Nakamachi T, Ohtaki H, Morikawa K, Takeda T, Shioda S, Aruga T: CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest. Neuropeptides 2006; 40:245-50
16. Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, Funahashi H, Matsuda K, Shioda S: Orexin-1 receptor expression after global ischemia in mice. Regul Pept 2005; 126: 49-54
17. Semenza GL: HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 2001; 107:1-3
18. Sikder D, Kodadek T: The neurohormone orexin stimulates hypoxia-inducible factor-1 activity. Genes Dev 2007; 21:2995-3005
19. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z: Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphateregulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003; 96:233-7
20. Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26:627-34
21. Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD: Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 2003; 34: 758-63
22. Badr AE, Yin W, Mychaskiw G, Zhang JH: Effect of hyper- baric oxygen on striatal metabolites: A microdialysis study in awake freely moving rats after MCA occlusion. Brain Res 2001; 916:85-90
23. Meguro T, Clower BR, Carpenter R, Parent AD, Zhang JH: Improved rat model for cerebral vasospasm studies. Neurol Res 2001; 23:761-6
24. Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ: Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 1998; 29:1037-46
25. Calvert JW, Yin W, Patel M, Badr A, Mychaskiw G, Parent AD, Zhang JH: Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res 2002; 951:1-8
26. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK: Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 1999; 260: 161-4
27. Suzuki R, Shimojima H, Funahashi H, Nakajo S, Yamada S, Guan JL, Tsurugano S, Uehara K, Takeyama Y, Kikuyama S, Shioda S: Orexin-1 receptor immunoreactivity in chemically identified target neurons in the rat hypothalamus. Neurosci Lett 2002; 324:5-8
28. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK: Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001; 435:6-25
29. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA: Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001; 103:777-97
30. Ramanjaneya M, Conner AC, Chen J, Kumar P, Brown JE, Jöhren O, Lehnert H, Stanfield PR, Randeva HS: Orexinstimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: Diverse roles for orexins A and B. J Endocrinol 2009; 202:249-61
31. Shin HS, Cho HS, Sung KW, Yoon BJ: Orexin-A increases cell surface expression of AMPA receptors in the striatum. Biochem Biophys Res Commun 2009; 378:409-13
32. Selbach O, Bohla C, Barbara A, Doreulee N, Eriksson KS, Sergeeva OA, Haas HL: Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases. Acta Physiol 2010; 198: 277-85
33. Peltonen HM, Magga JM, Bart G, Turunen PM, Antikainen MS, Kukkonen JP, Akerman KE: Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors. Biochem Biophys Res Commun 2009; 385:408-12
34. Bassetti CL, Aldrich MS: Sleep electroencephalogram changes in acute hemispheric stroke. Sleep Med 2001; 2:185-94
35. Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, Lammers GJ, Nishida Y, Roelandse FW, Hungs M, Mignot E, Nishino S: CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001; 57:2253-8
36. Kastin AJ, Akerstrom V: Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 1999; 289:219-23
37. Jin KL, Mao XO, Greenberg DA: Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242-7
38. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR: Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 1999; 19:9821-30
39. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxiainduced ischemic tolerance in neonatal rat brain. Ann Neurol 2000; 48:285-96
40. Simon MC: Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab 2006; 3:150-1
41. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH: Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol 2005; 191:198-210
42. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR: Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999; 11:4159-70
43. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5
44. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP: Structure of an HIF-1alpha -pVHL complex: Hydroxyproline recognition in signaling. Science 2002; 296:1886 -9
45. Pagé EL, Robitaille GA, Pouysségur J, Richard DE: Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002; 277:48403-9
46. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275:26765-71
47. Zhou J, Schmid T, Brüne B: Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell 2003; 14:2216-25
48. Sandau KB, Fandrey J, Brüne B: Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 2001; 97:1009-15
49. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, Sato T: Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 2005; 579:2111-8